Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.
The price of Mind Medicine Inc (NASDAQ: MNMD) closed at $9.14 in the last session, down -5.58% from day before closing price of $9.68. In other words, the price has decreased by -$5.58 from its previous closing price. On the day, 1.63 million shares were traded. MNMD stock price reached its highest trading level at $9.7 during the session, while it also had its lowest trading level at $9.02.
Ratios:
We take a closer look at MNMD’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 7.27 and its Current Ratio is at 7.27. In the meantime, Its Debt-to-Equity ratio is 0.10 whereas as Long-Term Debt/Eq ratio is at 0.10.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Evercore ISI on January 28, 2025, initiated with a Outperform rating and assigned the stock a target price of $23.
On December 20, 2024, Chardan Capital Markets started tracking the stock assigning a Buy rating and target price of $20.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Jun 25 ’25 when Sullivan Mark sold 11,491 shares for $6.80 per share. The transaction valued at 78,139 led to the insider holds 305,130 shares of the business.
Karlin Daniel sold 7,848 shares of MNMD for $53,366 on Jun 25 ’25. The Chief Medical Officer now owns 438,329 shares after completing the transaction at $6.80 per share. On Jun 25 ’25, another insider, Barrow Robert, who serves as the Chief Executive Officer of the company, sold 26,491 shares for $6.80 each. As a result, the insider received 180,139 and left with 830,065 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, MNMD now has a Market Capitalization of 690557120 and an Enterprise Value of 500151840.
Stock Price History:
The Beta on a monthly basis for MNMD is 2.97, which has changed by -0.012958944 over the last 52 weeks, in comparison to a change of 0.15366066 over the same period for the S&P500. Over the past 52 weeks, MNMD has reached a high of $10.44, while it has fallen to a 52-week low of $4.70. The 50-Day Moving Average of the stock is 18.53%, while the 200-Day Moving Average is calculated to be 29.18%.
Shares Statistics:
According to the various share statistics, MNMD traded on average about 1.21M shares per day over the past 3-months and 1397690 shares per day over the past 10 days. A total of 75.51M shares are outstanding, with a floating share count of 72.87M. Insiders hold about 3.55% of the company’s shares, while institutions hold 54.01% stake in the company. Shares short for MNMD as of 1752537600 were 11224668 with a Short Ratio of 9.30, compared to 1749772800 on 11065859. Therefore, it implies a Short% of Shares Outstanding of 11224668 and a Short% of Float of 14.97.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
Earnings Estimates
Current recommendations for the stock of the company come from 7.0 analysts. The consensus estimate for the next quarter is -$0.38, with high estimates of -$0.3 and low estimates of -$0.44.
Analysts are recommending an EPS of between -$1.19 and -$1.6 for the fiscal current year, implying an average EPS of -$1.44. EPS for the following year is -$1.5, with 7.0 analysts recommending between -$0.6 and -$1.86.
